Expanded multi-antigen specific lymphocytes

· Children's National Research Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Expanded multi-antigen specific lymphocytes, covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors [Phase 1]